Connor, Clark & Lunn Investment Management (CC&L)
SPRY icon

Connor, Clark & Lunn Investment Management (CC&L)’s ARS Pharmaceuticals SPRY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SPRY Stock Details SPRY Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-80,641
Closed -$851K – 1588
2024
Q4 		$851K Buy
80,641
+3,433
+4% +$36.2K ﹤0.01% 991
2024
Q3 		$1.12M Buy
+77,208
New +$1.12M 0.01% 846